ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,072Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 252

$517K Total Retail Price of All Prescriptions

Rank: 93 out of 252

516 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 685 624 1 2
LISINOPRIL 562 456 2 3
LEVOTHYROXINE SODIUM 505 440 3 1
HYDROCODONE-ACETAMINOPHEN 431 319 S3 4 5
FUROSEMIDE 398 364 5 7
OMEPRAZOLE 361 279 6 6
METOPROLOL TARTRATE 319 267 7 10
METFORMIN HCL 314 268 8 9
POTASSIUM CHLORIDE 301 281 9 8
MELOXICAM 266 238 10 20
WARFARIN SODIUM 264 243 11 14
AMLODIPINE BESYLATE 243 215 12 4
DIGOXIN 229 209 13 44
METOPROLOL SUCCINATE 186 166 14 19
NEXIUM 186 119 14 23
CLONIDINE HCL 150 144 16 35
GLIPIZIDE 145 120 17 52
TRAMADOL HCL 138 98 18 17
SPIRONOLACTONE 136 114 19 53
GEMFIBROZIL 134 121 20 98
LOSARTAN POTASSIUM 132 132 21 24
ZOLPIDEM TARTRATE 130 114 22 21
CITALOPRAM HBR 127 74 23 15
CARVEDILOL 123 104 24 22
CLOPIDOGREL 122 116 25 29
KLOR-CON M20 115 90 26 69
TRIAMTERENE-HCTZ 114 92 27 33
ATORVASTATIN CALCIUM 108 91 28 16
LOVASTATIN 108 98 28 39
TRAZODONE HCL 103 84 30 31
ATENOLOL 100 77 31 18
GLYBURIDE 98 72 R 32 78
HYDROCHLOROTHIAZIDE 95 88 33 13
PREDNISONE 94 87 34 42
TAMSULOSIN HCL 93 92 35 26
GABAPENTIN 92 75 36 11
DILTIAZEM ER 89 78 37 86
CIPROFLOXACIN HCL 88 73 38 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 74 38 25
AMOXICILLIN 87 78 40 122
DONEPEZIL HCL 85 83 41 28
CRESTOR 85 73 41 34
DIOVAN 84 84 43 38
ALLOPURINOL 80 75 44 30
LYRICA 77 62 45 66
FAMOTIDINE 73 67 46 59
LOSARTAN-HYDROCHLOROTHIAZIDE 71 51 47 49
PLAVIX 68 63 48 43
DIOVAN HCT 68 51 48 65
ALENDRONATE SODIUM 66 66 50 32
ISOSORBIDE DINITRATE 64 64 51 250
PRAVASTATIN SODIUM 58 42 52 12
DOXAZOSIN MESYLATE 54 46 53 73
MECLIZINE HCL 54 54 53 136
METHYLPREDNISOLONE 53 43 55 118
CELEBREX 53 52 55 101
FLUOXETINE HCL 51 38 57 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.